Back to
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
MRTX22 quarters
Position history for
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in MIRATI THERAPEUTICS INC
As of its Q4 2023 13F, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS held 65,534 shares of MRTX (Mirati Therapeutics), worth $3.9M. UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS' 13F filings listed MRTX from Q4 2018 to Q4 2023, 21 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$291,850
Total Shares Change
-6,880
Quarter-by-Quarter History
Other major holders of MRTX: Avoro Capital Advisors LLC